Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CANEUTREAT

Financiado

Cerrado

Decrypting neuro-cancer crosstalk in pediatric cancers of the peripheral nervous...

Decrypting neuro-cancer crosstalk in pediatric cancers of the peripheral nervous system Cancer neuroscience has emerged as a major axis of cancer biology, at the crossroad of two biological areas. Multi-layered dialogs between cancer and nervous contingents have started to be unravelled, with pivotal roles of the ner... ver más

31/01/2029

CNRS

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-01-18

ERC-2023-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

CNRS

1.84M€ | Lider

Proyectos interesantes

SAF2009-08629

Medical Technol...

Applied Physics

73K€ Cerrado

SAF2016-80412-P

Medical Technol...

Applied Physics

157K€ Cerrado

RYC-2013-13365

Medical Technol...

Applied Physics

309K€ Cerrado

SAF2010-21729

Medical Technol...

Applied Physics

109K€ Cerrado

JCI-2011-08957

Medical Technol...

Applied Physics

96K€ Cerrado

Gal3-BrainMets

Medical Technol...

Applied Physics

170K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 60 meses Fecha Inicio: 2024-01-18
Fecha Fin: 2029-01-31

Líder del proyecto

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer neuroscience has emerged as a major axis of cancer biology, at the crossroad of two biological areas. Multi-layered dialogs between cancer and nervous contingents have started to be unravelled, with pivotal roles of the nervous system in tumor initiation, growth and invasion, in turn amplified by cancer-induced hijacking of nervous functions. Specifically, brain tumors were shown to be integrated in bona fide neuron-to-cancer synaptic networks but also to capture neural-activity dependent released factors that boost their tumor properties. In the last years, this completely rewired the view of high-grade gliomas, especially those arising in the pediatric population, suggesting specific vulnerabilities when neural networks are being shaped. The knowledge regarding neuro-cancer crosstalk in the peripheral nervous system (PNS) is far more fragmented, and is even obscure in malignancies arising within peripheral nervous tissues. Neuroblastoma (NB) is an emblematic, deadly, pediatric cancer of the PNS, with primary tumors that develop in sympathetic ganglia or in the adrenal gland. Despite its occurrence in sites of active central-to-PNS synaptic contacts, whether neural activity impacts on NB tumor features and metastatic progression is fully unknown. We have conceived a model of NB that reproduces the embryonic and nervous microenvironment in which it arises but also the sequence of its metastatic progression. Guided by preliminary data, the objective of the proposal is to decrypt the panel of neuro-cancer functional interplays in NB, at the anatomical, electrophysiological and molecular level. We will deploy multidisciplinary and cutting-edge approaches to provide a comprehensive and dynamic picture of neuro-NB dialogs, in relevant models for this pediatric cancer. Our underlying aims are to identify novel entry points for therapeutic strategies, and to define subtypes of NB that would benefit from neuro-related therapies.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores